Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.
Vlachopoulos C, Xaplanteris P, Aboyans V, Brodmann M, Cífková R, Cosentino F, De Carlo M, Gallino A, Landmesser U, Laurent S, Lekakis J, Mikhailidis DP, Naka KK, Protogerou AD, Rizzoni D, Schmidt-Trucksäss A, Van Bortel L, Weber T, Yamashina A, Zimlichman R, Boutouyrie P, Cockcroft J, O'Rourke M, Park JB, Schillaci G, Sillesen H, Townsend RR. Vlachopoulos C, et al. Among authors: sillesen h. Atherosclerosis. 2015 Aug;241(2):507-32. doi: 10.1016/j.atherosclerosis.2015.05.007. Epub 2015 May 16. Atherosclerosis. 2015. PMID: 26117398 Free article. Review.
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Amarenco P, Goldstein LB, Callahan A 3rd, Sillesen H, Hennerici MG, O'Neill BJ, Rudolph AE, Simunovic L, Zivin JA, Welch KM; SPARCL Investigators. Amarenco P, et al. Among authors: sillesen h. Atherosclerosis. 2009 Jun;204(2):515-20. doi: 10.1016/j.atherosclerosis.2008.09.008. Epub 2008 Sep 18. Atherosclerosis. 2009. PMID: 18962621 Clinical Trial.
The year 2017 in cardiology: aorta and peripheral circulation.
Aboyans V, Braekkan S, Mazzolai L, Sillesen H, Venermo M, De Carlo M; ESC Working Group on Aorta and Peripheral Vascular Diseases. Aboyans V, et al. Among authors: sillesen h. Eur Heart J. 2018 Mar 1;39(9):730-738. doi: 10.1093/eurheartj/ehx800. Eur Heart J. 2018. PMID: 29300868 Review. No abstract available.
International public awareness of peripheral artery disease.
Bauersachs R, Brodmann M, Clark C, Debus S, De Carlo M, Gomez-Cerezo JF, Madaric J, Mazzolai L, Ricco JB, Sillesen H, Aboyans V; EUROPAD Writing Group. Bauersachs R, et al. Among authors: sillesen h. Vasa. 2021 Jul;50(4):294-300. doi: 10.1024/0301-1526/a000945. Epub 2021 Mar 1. Vasa. 2021. PMID: 33645232
Progress in aorta and peripheral cardiovascular disease research.
Mazzolai L, Alatri A, Rivière AB, De Carlo M, Heiss C, Espinola-Klein C, Schlager O, Sillesen H, Staub D, Rodriguez-Palomares JF, Verstraeten A, Aboyans V; WG on aorta and peripheral vascular diseases. Mazzolai L, et al. Among authors: sillesen h. Cardiovasc Res. 2021 Jul 27;117(9):2045-2053. doi: 10.1093/cvr/cvab144. Cardiovasc Res. 2021. PMID: 33892507 Free PMC article.
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy.
Aboyans V, Bauersachs R, Mazzolai L, Brodmann M, Palomares JFR, Debus S, Collet JP, Drexel H, Espinola-Klein C, Lewis BS, Roffi M, Sibbing D, Sillesen H, Stabile E, Schlager O, De Carlo M. Aboyans V, et al. Among authors: sillesen h. Eur Heart J. 2021 Oct 14;42(39):4013-4024. doi: 10.1093/eurheartj/ehab390. Eur Heart J. 2021. PMID: 34279602
275 results